May 12, 2022
House Energy & Commerce Health Subcommittee advances bipartisan user fee, mental health and research bills to full committee
On May 11, the House Energy & Commerce Subcommittee on Health advanced six bipartisan health care bills to the full House Energy & Commerce Committee. Committee leaders expressed strong support for the bills and the importance of passing legislation to reauthorize the Food and Drug Administration's (FDA) user fee agreements, the Food and Drug Amendments of 2022 (H.R. 7667), before the current user fee agreements expire on September 30. Committee Chair Frank Pallone (D-NJ) noted that while CURES 2.0 was not included in the markup, the committee was able to make progress on key priorities — such as the Advanced Research Project Agency-Health Act, or the ARPA-H Act, (H.R. 5585) — and that the committee will work to advance the rest of CURES 2.0 on a bipartisan basis.
Committee leaders also expressed their support for legislation to support mental health care and substance use disorders — the Restoring Hope for Mental Health and Well-Being Act of 2022 (H.R. 7666) and the Keeping Incarceration Discharges Streamlined for Children and Accommodating Resources in Education Act, also known as the KIDS CARES Act, (H.R. 7233) — with Subcommittee Chair Anna Eshoo (D-CA) noting the need to improve mental health screening for children in schools and Subcommittee Ranking Member Brett Guthrie (R-KY) discussing the impact of fentanyl overdoses on the country. Subcommittee Chair Eshoo (D-CA) also praised the committee's work on the South Asian Heart Health Awareness Act of 2021 (H.R. 3771) and Gabriella Miller Kids First Research Act 2.0 (H.R. 623).
More information is available here.
Additional information is also available in the attached Tax Alert.
House Energy & Commerce Health Subcommittee advances bipartisan user fee